Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
1.220
+0.080 (7.02%)
Mar 3, 2026, 4:00 PM EST - Market closed
Elutia Employees
Elutia had 51 employees as of December 31, 2024. The number of employees decreased by 3 or -5.56% compared to the previous year.
Employees
51
Change (1Y)
-3
Growth (1Y)
-5.56%
Revenue / Employee
$426,392
Profits / Employee
-$519,059
Market Cap
52.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 51 | -3 | -5.56% | 51 | 0 |
| Dec 31, 2023 | 54 | -110 | -67.07% | 54 | 0 |
| Sep 30, 2023 | 53 | -113 | -68.07% | 53 | 0 |
| Jun 30, 2023 | 151 | -11 | -6.79% | 151 | 0 |
| Mar 31, 2023 | 144 | -13 | -8.28% | 144 | 0 |
| Dec 31, 2022 | 164 | -12 | -6.82% | 164 | 0 |
| Sep 30, 2022 | 166 | -10 | -5.68% | 166 | 0 |
| Jun 30, 2022 | 162 | -13 | -7.43% | 162 | 0 |
| Mar 31, 2022 | 157 | -14 | -8.19% | 157 | 0 |
| Dec 31, 2021 | 176 | 13 | 7.98% | 176 | 0 |
| Sep 30, 2021 | 176 | 20 | 12.82% | 176 | 0 |
| Jun 30, 2021 | 175 | 25 | 16.67% | 175 | 0 |
| Mar 31, 2021 | 171 | 21 | 14.00% | 171 | 0 |
| Dec 31, 2020 | 163 | - | - | 155 | 8 |
| Sep 30, 2020 | 156 | - | - | 156 | 0 |
| Jun 30, 2020 | 150 | - | - | 150 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Outset Medical | 310 |
| Pulmonx | 291 |
| Cytosorbents | 149 |
| Spectral AI | 78 |
| Picard Medical | 75 |
| electroCore | 73 |
| IceCure Medical | 66 |
ELUT News
- 1 day ago - Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - GlobeNewsWire
- 6 days ago - Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - GlobeNewsWire
- 13 days ago - Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ - GlobeNewsWire
- 7 weeks ago - Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - GlobeNewsWire
- 7 weeks ago - Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - GlobeNewsWire
- 4 months ago - Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development - GlobeNewsWire
- 4 months ago - Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire